Xiaolei Chai

机构：Institute of Biomedical Science, East China Normal University

发表论文 17 篇 · 总被引 178 次 · h-index 7

代表论文

• The lactate receptor HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in colorectal cancer (2025 · Nature Immunology · 被引 67)
• Discovery of Pyridinone Derivatives as Potent, Selective, and Orally Bioavailable Adenosine A 2A Receptor Antagonists for Cancer Immunotherapy (2023 · Journal of Medicinal Chemistry · 被引 25)
• From a Designer Drug to the Discovery of Selective Cannabinoid Type 2 Receptor Agonists with Favorable Pharmacokinetic Profiles for the Treatment of Systemic Sclerosis (2020 · Journal of Medicinal Chemistry · 被引 19)
• A Novel Small Molecular Prostaglandin Receptor EP4 Antagonist, L001, Suppresses Pancreatic Cancer Metastasis (2022 · Molecules · 被引 18)
• Discovery of a Highly Potent Oxysterol Receptor GPR183 Antagonist Bearing the Benzo[ d ]thiazole Structural Motif for the Treatment of Inflammatory Bowel Disease (IBD) (2024 · Journal of Medicinal Chemistry · 被引 12)
• Enzyme-free sandwich-type electrochemical immunosensor based on high catalytic binary PdCu mesoporous metal nanoparticles and conductive black phosphorous nanosheets for ultrasensitive detection of pro-SFTPB in non-small cell lung cancer (2022 · Journal of Electroanalytical Chemistry · 被引 12)